AssetMark’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
AssetMark's AMRX Position: Q3 2026 in Review
AssetMark held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 22 shares worth $443. The position accounts for ﹤0.01% of the portfolio, ranked #3438.
AssetMark first reported a position in AMRX in Q2 2018 and has held it in 7 quarters since. The position peaked at $41K in Q3 2018. 264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- AssetMark held 22 shares of Amneal Pharmaceuticals worth $443 as of Q3 2026.
- AssetMark left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
- Amneal Pharmaceuticals made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3438 holding.
- AssetMark first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 7 quarters since.
- AssetMark's Amneal Pharmaceuticals position peaked at $41K in Q3 2018.
- 264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.